Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares, rose in value on Wednesday, March 26, with the stock price down by -1.15% to the previous day’s close as strong demand from buyers drove the stock to $3.44.
Actively observing the price movement in the last trading, the stock closed the session at $3.48, falling within a range of $3.33 and $3.5199. The value of beta (5-year monthly) was 0.929. Referring to stock’s 52-week performance, its high was $15.18, and the low was $3.42. On the whole, IOVA has fluctuated by -35.58% over the past month.
With the market capitalization of Iovance Biotherapeutics Inc currently standing at about $1.13 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 453.14M, with a low estimate of 74.65M and a high estimate of 102.8M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 83.27M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that IOVA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of IOVA currently trading nearly -9.55% and -30.99% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 27.71, while the 7-day volatility ratio is showing 5.34% which for the 30-day chart, stands at 7.17%. Furthermore, Iovance Biotherapeutics Inc (IOVA)’s beta value is 1.02, and its average true range (ATR) is 0.28.
A comparison of Iovance Biotherapeutics Inc (IOVA) with its peers suggests the former has fared considerably weaker in the market. IOVA showed an intraday change of -1.15% in last session, and over the past year, it shrunk by -77.10%%.
Data on historical trading for Iovance Biotherapeutics Inc (NASDAQ:IOVA) indicates that the trading volumes over the past 10 days have averaged 7.87 and over the past 3 months, they’ve averaged 9.53 million. According to company’s latest data on outstanding shares, there are 305.25 million shares outstanding.
Nearly 19.01% of Iovance Biotherapeutics Inc’s shares belong to company insiders and institutional investors own 65.49% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 67.3 million shares as on 2025-03-14, resulting in a short ratio of 5.69. According to the data, the short interest in Iovance Biotherapeutics Inc (IOVA) stood at 2252.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 63.6 million. The stock has fallen by -53.51% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IOVA stock heading into the next quarter.
